VYNE Therapeutics Inc - VYNE - stock price prediction, stock price target, analyst ratings from 4 analysts

VYNE Therapeutics Inc has a share price target of US$ 2, revenue growth forecast of -59.6%, and profit growth estimate of -66.7% for FY26, based on top 4 analyst calls.